February 27, 2020 / 11:21 PM / a month ago

BRIEF-Biodelivery Sciences Announces Phase I Clinical Trial Results At The American Academy Of Pain Medicine’S 36Th Annual Meeting

Feb 27 (Reuters) - BioDelivery Sciences International Inc :

* BIODELIVERY SCIENCES ANNOUNCES PHASE I CLINICAL TRIAL RESULTS AT THE AMERICAN ACADEMY OF PAIN MEDICINE’S 36TH ANNUAL MEETING

* BIODELIVERY SCIENCES - IMMEDIATE RELEASE ORAL OXYCODONE HCL ASSOCIATED WITH A DOSE-DEPENDENT DECREASE IN RESPIRATORY DRIVE COMPARED TO PLACEBO Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below